Truqap is actually a kinase inhibitor that works by blocking pathways that support the cancer cells survive and develop, so lowers cancer progress. Truqap is from a class of medicines referred to as an AKT inhibitor. Truqap obtained FDA approval on November seventeen, 2023, after good outcomes from your CAPItello-291 https://forskolin80235.ltfblog.com/33701101/trastuzumab-deruxtecan-for-dummies